Question 1

What is ICD-10 code Z12.89?

Accepted Answer

Z12.89 is the ICD-10-CM diagnosis code for encounter for screening for malignant neoplasm of other sites. A visit for screening tests to check for cancer at sites not listed in other screening codes. Z12.89 sits in the ICD-10-CM chapter for factors influencing health status and contact with health services (z00-z99), within the section covering persons encountering health services for examinations (z00-z13).

Z12.89 is a billable ICD-10-CM code but does not map to a payment HCC under the CMS-HCC V28, V24, ESRD, or RxHCC risk adjustment models. It can be reported on Medicare Advantage encounter data submissions but it does not contribute to a beneficiary's RAF score and therefore does not affect risk-adjusted payments to the plan.

This is a catch-all code for cancer screening at uncommon sites.

Question 2

Is Z12.89 an HCC code?

Accepted Answer

No. Z12.89 is a billable ICD-10-CM code but does not map to any payment HCC category under the CMS-HCC V28, V24, ESRD, or RxHCC risk adjustment models. It can still be reported on Medicare Advantage encounter data submissions, but it does not contribute to the beneficiary's Risk Adjustment Factor (RAF) score and therefore does not affect the risk-adjusted capitation payment to the plan. V28 reached 100% phase-in for payment year 2026.

Question 3

Is Z12.89 billable?

Accepted Answer

Yes. Z12.89 is a billable ICD-10-CM code that can be reported on professional and institutional claims as a primary or secondary diagnosis when the provider documentation supports the specific condition described. Billable codes in ICD-10-CM are coded to the highest level of specificity available for the documented diagnosis. Z12.89 is current for fiscal year 2026 and remains in the active CMS ICD-10-CM code set published by the National Center for Health Statistics.

Question 4

What is the V28 vs V24 difference for Z12.89?

Accepted Answer

Z12.89 does not map to a payment HCC under either the CMS-HCC V28 risk adjustment model or the older V24 model. V28 reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition. Because neither model rewards Z12.89 with a risk adjustment factor, it contributes zero to a Medicare Advantage beneficiary's RAF score in either version. Coders should check whether provider documentation supports a more specific child code that does map to a payment HCC.

Question 5

What should coders know when reporting Z12.89?

Accepted Answer

This is a catch-all code for cancer screening at uncommon sites Document the specific site being screened to ensure the most appropriate code is selected

HCC Buddy Code Card

Z12.89

Is Z12.89 an HCC code?

Get the V28 RAF + MEAT cheat sheet

What This Code Means

Coding Tips

Child Codes

Code Hierarchy

Work Z12.89 in HCC Buddy

Z12.89 ICD-10-CM Code: Encounter for screening for malignant neoplasm of other sites

HCC Buddy Code Card

Z12.89

Is Z12.89 an HCC code?

Get the V28 RAF + MEAT cheat sheet

What This Code Means

Coding Tips

Child Codes

Code Hierarchy

Work Z12.89 in HCC Buddy